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A B S T R A C T
The nuclear protein HMGB1 (high mobility group box 1) is secreted by monocytes-macrophages in response to
inﬂammatory stimuli and serves as a danger-associated molecular pattern. Acetylation and phosphorylation of
HMGB1 are implicated in the regulation of its nucleocytoplasmic translocation for secretion, although in-
ﬂammatory stimuli are known to induce H2O2 production. Here we show that H2O2-induced oxidation of
HMGB1, which results in the formation of an intramolecular disulﬁde bond between Cys23 and Cys45, is ne-
cessary and suﬃcient for its nucleocytoplasmic translocation and secretion. The oxidation is catalyzed by per-
oxiredoxin I (PrxI) and PrxII, which are ﬁrst oxidized by H2O2 and then transfer their disulﬁde oxidation state to
HMGB1. The disulﬁde form of HMGB1 showed higher aﬃnity for nuclear exportin CRM1 compared with the
reduced form. Lipopolysaccharide (LPS)–induced HMGB1 secretion was greatly attenuated in macrophages
derived from PrxI or PrxII knockout mice, as was the LPS-induced increase in serum HMGB1 levels.
1. Introduction
HMGB1 is a nuclear protein that functions as a DNA chaperone
during chromatin reorganization and transcriptional regulation [1,2]
and which shuttles between the nucleus and cytoplasm of mammalian
cells. Exit of HMGB1 from the nucleus occurs by both passive diﬀusion
and an actively controlled pathway mediated by chromosome region
maintenance protein 1 (CRM1), with import of the protein back into the
nucleus also being actively controlled by karyopherin-α1 [3,4]. The
traﬃcking of HMGB1 between the nucleus and cytoplasm has been
thought to be regulated by protein acetylation and phosphorylation
[3,4]. When HMGB1 is acetylated or phosphorylated at its nuclear lo-
calization signal (NLS) sequences in the nucleus, it is able to exit the
nucleus but reimport is inhibited, resulting in its accumulation in the
cytoplasm. HMGB1 is passively released from cells via necrosis, and is
actively secreted from monocytes and macrophages in response to ex-
posure of the cells to inﬂammatory stimuli. HMGB1 does not contain a
leader sequence, with such secretion occurring through a vesicle-
mediated pathway [5].
Secreted HMGB1 acts as a damage-associated molecular pattern
(DAMP) molecule to signal danger to surrounding cells, triggers in-
ﬂammation, and activates innate and adaptive immunity by binding to
a plethora of cell surface receptors including Toll-like receptor 2
(TLR2), TLR4, TLR9, receptor for advanced glycation end products
(RAGE), and C-X-C chemokine receptor 4 (CXCR4) when bound to C-X-
C motif chemokine ligand 12 (CXCL12). HMGB1 also interacts with the
pathogen-associated molecular pattern (PAMP) molecules LPS and li-
poteichoic acid [6,7] as well as with endogenous CXCL12 [8], inter-
leukin (IL)-1β [9], and nucleosomes [10] to augment inﬂammation.
Furthermore, HMGB1 mediates autophagosome formation by binding
to beclin-1 [11], and it inhibits polyglutamine aggregate formation in
the cytoplasm through a chaperone-like function [12].
HMGB1 contains three conserved cysteine residues: Cys23, Cys45,
and Cys106. The redox state of these cysteines gives rise to at least three
forms of HMGB1 that are designated “reduced HMGB1” (all three cy-
steine residues in the thiol state), “disulﬁde HMGB1” (an
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intramolecular disulﬁde bond between Cys23 and Cys45; Cys106 in the
thiol state), and “sulfonic HMGB1” (all three cysteines in the hyper-
oxidized sulfonic acid state). The speciﬁc functions of HMGB1 have
recently been shown to be dependent on the redox state of its cysteines
[13], with reduced HMGB1 forming a complex with CXCL12 to promote
the migration of immune cells [14], disulﬁde HMGB1 (but not reduced
HMGB1) interacting with a TLR4 adaptor protein to activate TLR4 and
induce proinﬂammatory responses [15], and sulfonic HMGB1 mani-
festing neither cytokine- nor chemokine-like function [16]. HMGB1
present inside cells is predominantly in the fully reduced state, whereas
the presence of disulﬁde HMGB1 in serum has been associated with
inﬂammation-related pathologies [17,18]. However, fundamental is-
sues regarding the oxidation of Cys23 and Cys45 of HMGB1—including
the mechanism by which such oxidation occurs in response to in-
ﬂammatory signals, the subcellular compartment where the oxidation
occurs, and the eﬀect of oxidation on HMGB1 secretion—have re-
mained unclear.
Hydrogen peroxide (H2O2) is produced by cells in response to var-
ious extracellular stimuli and propagates intracellular signaling by
oxidizing protein thiols [19]. Cells are also equipped with H2O2-elim-
inating enzymes such as catalase, glutathione peroxidase, and perox-
iredoxin (Prx). The Prx family of peroxidases reduces H2O2 or alkyl
peroxide, with the thiol of a conserved cysteine residue (the peroxidatic
Cys, or CP–SH) serving as the site of oxidation by peroxides. In addition
to CP–SH located in the NH2-terminal region of the molecule, most Prx
enzymes contain an additional conserved cysteine (the resolving Cys, or
CR–SH) in the COOH-terminal region. Mammalian cells express six
isoforms of Prx (PrxI to PrxVI) that diﬀer in their subcellular localiza-
tion [20]. PrxI and PrxII are thus localized in the cytosol and nucleus.
During the catalytic cycle of Prx enzymes, CP–SH is ﬁrst oxidized by
H2O2 to sulfenic acid (CP–SOH), which then reacts with CR–SH to form a
disulﬁde that is subsequently reduced by an appropriate electron donor
to complete the cycle.
Prxs are abundant proteins, with PrxI and PrxII together con-
stituting a total of 0.2% to 1% of soluble protein in cultured mammalian
cells [21]. In addition, Prxs possess an active-site pocket that gives rise
to a high-aﬃnity peroxide binding site [22]. This pocket is arranged so
as to elicit rapid oxidation of CP–SH by H2O2, with the second-order
rate constant for this oxidation being several orders of magnitude
greater than that for the oxidation of thiols in well-characterized H2O2
target proteins. It was thus at ﬁrst unclear how H2O2 is able to oxidize
speciﬁc cysteine thiols of its target proteins in the presence of such
abundant and eﬃcient antioxidant enzymes. Two mechanisms to
overcome this kinetic disadvantage with regard to oxidation by H2O2
have been proposed. One mechanism is transient localized inactivation
of Prxs so as to protect H2O2 from destruction, which allows the ac-
cumulation of H2O2 in speciﬁc regions of the cell without global redox
disturbance. The second mechanism is oxidation of PrxI or PrxII by
H2O2 and subsequent transfer of the oxidation state to the target pro-
tein. Such an H2O2 sensor and transducer function of Prxs has been
demonstrated in the oxidation of several proteins including protein
disulﬁde isomerase (PDI) [23,24], apoptosis signal–regulating kinase 1
[25], mitogen-activated protein kinase (MAPK) [26,27], and STAT3
[28].
We now show that disulﬁde formation between Cys23 and Cys45 of
HMGB1 is mediated by PrxI and PrxII in the nucleus and is essential for
the nucleocytoplasmic translocation and secretion of HMGB1.
Inﬂammatory stimuli such as LPS and TNFα as well as chemicals in-
cluding phorbol 12-myristate 13-acetate (PMA) and trichostatin A
(TSA) have been shown to induce the phosphorylation or acetylation of
HMGB1 at its NLS sequences and thereby to promote its cytoplasmic
translocation for secretion [3,4]. These inﬂammatory stimuli and che-
micals also induce the intracellular production of H2O2. We show that
H2O2 is ﬁrst sensed by PrxI and PrxII, which then transfer the oxidant
signal to HMGB1, resulting in formation of the Cys23–Cys45 disulﬁde
bond. Importantly, whereas such disulﬁde formation is suﬃcient for
HMGB1 secretion, posttranslational modiﬁcation (PTM) of the NLS
sequences is not essential for secretion but rather appears to function
cooperatively with disulﬁde formation in this regard. Finally, we found
that the LPS-induced increase in the circulating concentration of
HMGB1 was signiﬁcantly attenuated in mice lacking the PrxI or PrxII
gene.
2. Materials and methods
2.1. Cell cultures
HEK293T and MEF cells were cultured in 10% FBS-Dulbecco's
modiﬁed Eagle's medium (DMEM) supplemented with 100 U/mL pe-
nicillin, 100 μg/mL streptomycin, and 2mM L-glutamine at 37 °C under
5% CO2. HEK293-hTLR4/MD2/CD14 (Invivogen) cells were cultured in
the abovementioned culture medium supplemented with 10 μg/mL
blasticidin and 50 μg/mL hygromycin B. Primary mouse BMDM cells
were prepared from male C57BL/6 WT, PrxI-, and PrxII-KO mice
[29,30]. Brieﬂy, bone marrow cells were obtained by ﬂushing bone
marrow of femurs and tibias after euthanasia and then maintained in
complete DMEM medium containing 20% L929 culture supernatant for
7 days [31]. BMDM cells were collected after incubation at 37 °C for
4min with 0.25% trypsin-EDTA solution and were gently resuspended
in complete DMEM.
2.2. Animals and mouse study
C57BL/6 WT, PrxI-, and PrxII-KO mice were used [29,30]. Mice
were performed on age- and gender-matched randomly assigned 8- to
12-week-old male mice conducted according to procedures approved by
the Institutional Animal Care and Use Committee of the Yonsei La-
boratory Animal Research Center (YLARC, 2015-0275). Up to ﬁve mice
per cage were housed in ventilated cages in a 12 h light and 12 h dark
cycle. RT was at 22 °C, and they were fed with autoclaved standard
rodent food and with drinking water at libitum.
C57BL/6 WT, PrxI- and PrxII-KO mice were used to investigate the
eﬀect of PrxI/II on HMGB1 secretion in vivo. Mice were in-
traperitoneally injected with 5mg/kg LPS and then serum samples were
collected at 1 and 16 h for TNF-α and HMGB1 measurements, respec-
tively. Serum HMGB1 (IBL international) and TNF-α (R&D System)
were measured according to the manufacturer's protocols.
2.3. Plasmids and in situ mutagenesis
Myc- or enhanced green ﬂuorescent protein (EGFP)-tagged
HMGB1(WT), HMGB1(C23S), and HMGB1(C45S) were inserted into the
pCMV-Myc (Clontech) or pEGFP-N1 (Clontech) plasmid for mammalian
cell expression. Myc/His6-tagged human PrxI and PrxII plasmids were
generated using the pcDNA™3.1/Myc-His vector (Invitrogen). Myc/
His6-tagged PrxI(C52S), PrxI(C173S), PrxI(C52S/173S) plasmids were
generated using the QuikChange site-directed mutagenesis kit
(Agilent). Streptavidin-binding peptide (SBP)-tagged PrxII(WT), PrxII
(C51S), PrxII(C172S), and PrxII(C51S/172S) plasmids were kindly
provided by Dr. Tobias P. Dick (German Cancer Research Center,
Heidelberg, Germany) [28], and subcloned into pcDNA™3.1/Myc-His.
The HMGB1(NLS1/2A)-GFP plasmid, a mutant plasmid wherein all the
phosphorylation residues of six serines are changed to alanines in the
NLS1 and 2 regions [4], was subcloned into pCMV-Myc. Myc-tagged
HMGB1(NLS1/2R) plasmid, a mutant plasmid wherein all the acetyla-
tion residues of six lysines (K27, 28, 29 in NLS1 and K181, 182, 183 in
NLS2) are changed to arginines [3], was generated using the Quik-
Change site-directed mutagenesis kit. Primer list for HMGB1 and PrxI/II
constructs are described in Table S1.
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2.4. Cell culture, transfection, and reagents
Plasmid transfections were carried out using Fugene HD reagent
(Promega Corporation) or electroporation system (Invitrogen™) by
MicroPorator-mini (Digital Bio). The histone deacetylase inhibitor TSA
(Sigma-Aldrich) and PKC activator PMA (Sigma-Aldrich) for acetylation
and phosphorylation, respectively, as well as H2O2 (Sigma-Aldrich) and
glucose oxygenase (GOX) from Aspergillus niger (Sigma-Aldrich) for
oxidation were used. LPS (Escherichia coli 0111:B4, 49180) (Sigma-
Aldrich) and TNF-α (ATgen) were used for pro-inﬂammatory signaling.
NAC (Enzo Life Sciences) was used as an antioxidant.
2.5. Measurement of HMGB1 secretion
To analyze the secretion of HMGB1 in the supernatants, culture
media were replaced with serum-free OPTI-MEM medium (Gibco®) and
treated with various stimulants. The culture supernatants were har-
vested and concentrated via Amicon Centricon ﬁltration (Merck
Millipore) after removing cell debris. Western blotting analysis was
performed with rabbit anti-HMGB1 (Abcam, Ab18256) or mouse anti-
Myc antibody (Invitrogen Life Technologies, 13-2500) as described
below. Quantitative determination of HMGB1 in mouse serum or
BMDM culture medium was performed using the HMGB1 ELISA Kit (IBL
international) according to the manufacturer's protocol.
2.6. In vitro binding of PrxI/II proteins to HMGB1
HMGB1 and PrxI or PrxII proteins were puriﬁed. A mixture (total of
1 ml) of HMGB1 (0.5 μg/ml) and PrxI (0.4 μg/ml) or PrxII (0.4 μg/ml)
was added with 0, 5, 50, and 500 μM DTT in the condition of slowly
increasing amount of H2O2 to 50 μM and incubated overnight at 4 °C to
observe the disulﬁde intermediate formation of HMGB1-PrxI/II. The
mixtures were immunoprecipitated with mouse monoclonal anti-
HMGB1 Ab (Abcam, Ab12029) and analysed in reducing SDS-PAGE.
Immunoblots were performed with rabbit polyclonal anti-PrxI
(AbFrontier, LF-PA0095), rabbit monoclonal anti-PrxII (Abcam,
Ab109367) and rabbit polyclonal anti-HMGB1 (Abcam, AB18256) an-
tibodies.
2.7. Confocal microscopy
Nucleocytoplasmic translocation of HMGB1 was observed under
various stimulation conditions. HEK293T and HEK293-hTLR4/MD2/
CD14 cells (InvivoGen) were transfected with EGFP-tagged
HMGB1(WT), HMGB1(C23S), and HMGB1(C45S) plasmids and cul-
tured in a LabTekTM II chamber (Nunc™) for 48 h. Cells were treated
with 5 mU/mL GOX, 50 μMH2O2, 250 nM PMA, 50 ng/mL TNF-α, and
10 ng/mL TSA for 2 h. HEK293-hTLR4/MD2/CD14 cells were treated
with 1 μg/mL LPS for 1 h. Cells were ﬁxed with 4% paraformaldehyde
(Biosesang) in PHEM buﬀer for 20 min at room temperature (RT) and
washed with cold PBS. After mounting with 4′,6′-diamidino-2-pheny-
lindole (Vector Laboratories), over 200 cells were observed to count the
proportion of cytoplasmic HMGB1 (+) cells under confocal FV1000
microscopy (Olympus).
2.8. Proximity ligation assay (PLA)
The molecular interactions between HMGB1 and PrxI/II or CRM1
proteins were evaluated using a Duolink II Detection kit (Olink
Bioscience). Brieﬂy, HEK293T cells were cultured in eight well cham-
bers (Nunc™) and transfected with HMGB1(WT), HMGB1(C23S), or
HMGB1(C45S) plasmids. Cells were ﬁxed with 4% paraformaldehyde in
PHEM buﬀer for 20min at RT. Cells were incubated with a blocking
agent for 1 h, and rabbit polyclonal anti-PrxI and anti-PrxII were added
and incubated overnight with either mouse monoclonal anti-HMGB1 or
anti-Myc for endogenous or exogenous HMGB1, respectively. Mouse
monoclonal anti-CRM1 (Santa Cruz Biotechnology, SC-5595) was in-
cubated with rabbit polyclonal anti-HMGB1 to identify the HMGB1-
CRM1 interaction. After three subsequent washes, PLA probes were
applied and incubated for 1 h in a humidity chamber at 37 °C. Unbound
PLA probes were removed and the samples were incubated in the li-
gation solution for 1 h. For ampliﬁcation, polymerase was applied with
ﬂuorescently labeled oligonucleotides for 100min at 37 °C. The ampli-
ﬁed ﬂuorescence-labeled oligonucleotide was visible as a distinct
ﬂuorescent spot and images were taken by confocal microscopy.
2.9. Mass spectrometry (LC-MS/MS)
To identify the disulﬁde bond formation between Cys23 and Cys45
of HMGB1 and free Cys106 of HMGB1, HEK293T cells were transfected
with the Myc-HMGB1 plasmid and then stimulated with 5 mU/mL GOX
for 2 h. 50mM N-Ethyl maleimide (NEM; Sigma-Aldrich) was added to
WCLs for labeling of reactive cysteine residues and the protein super-
natant was applied to anti-Myc tagged-magnetic beads (Bio-Rad). The
puriﬁed Myc-HMGB1 protein was treated with or without 5mM DTT.
The NEM labeled or unlabeled Myc-HMGB1 was separated on SDS-
PAGE followed by Coomassie Blue staining. LC-MS/MS products were
analysed after in-gel digested with trypsin at the Yonsei Proteome
Research Center (Seoul, Korea).
2.10. Western blot analysis and immunoprecipitation (IP)
HEK293T or MEF cells in six-well plates were transfected with
plasmids using FuGene HD or electroporated using the MicroPorator-
mini. Cells were washed with phosphate buﬀered saline (PBS) and lysed
in 1×RIPA buﬀer (GenDEPOT) containing 150mM NaCl, 1% Triton X-
100, 1% deoxycholic acid sodium salt, 0.1% SDS, 50mM Tris-HCl pH
7.5, 2 mM EDTA, and protease inhibitor cocktail (GenDEPOT). For thiol
blocking, 50mM NEM was added to inhibit the breakage or new dis-
ulﬁde bond formation. WCLs were centrifuged at 20,000×g for
10min at 4 °C. Protein sample buﬀer (100mM Tris-HCl pH 6.8, 2% SDS,
25% glycerol, 0.1% bromophenol blue, and with/without 5% β-mer-
captoethanol) was added to the WCLs followed by heating at 94 °C for
5min. Proteins (20 μg) were separated by molecular weight via SDS-
PAGE or nonreducing SDS-PAGE and transferred to nitrocellulose
membranes. Non-speciﬁc binding sites were blocked by incubating the
membranes in Tris-buﬀered saline (TBS) supplemented with 0.1%
Tween 20 and 5% w/v skim milk for 1 h. Anti-HMGB1, anti-PrxI, anti-
PrxII, anti-CRM1, anti-GAPDH (AbFrontier, LF-PA0095), anti-Sp1
(Santa Cruz Biotechnology, SC-59) antibodies were used. Membranes
were washed three times for 10min with TBS-Tween 20 and probed
with the appropriate horseradish peroxidase (HRP)-conjugated sec-
ondary Ab (Jackson ImmunoResearch) for 1 h. After washing three
times, an enhanced chemiluminescence substrate was then used for
visualization. Membranes were then stripped by submerging in
EzReprobe (ATTO Corporation) at RT for 30min.
IP was performed with 100–200 μg protein. Initially, 1 μg speciﬁc
Ab was conjugated with Dynabeads® protein G (Bio-Rad) at RT for 1 h.
Samples were added to 10 μL Ab conjugated-Dynabeads® Protein G at
4 °C for 18 h. The beads were washed three times with ice-cold PBS and
then mixed with protein sample buﬀer followed by heating at 94 °C for
5min. The proteins were separated using SDS-PAGE.
2.11. Nuclear/cytosolic fractionation
To determine the localization of the intracellular interaction be-
tween HMGB1 and PrxI or PrxII during conditions of increased in-
tracellular H2O2 levels, HEK293T cells were transfected with Myc
tagged HMGB1WT, HMGB1C23S, or HMGB1C45S with PrxI- or PrxII-Myc/
His6 plasmids and then treated with 50 μMH2O2 for 30min to induce
oxidative stress. Cells were harvested by centrifugation at 600×g for
5min at 4 °C. Nuclear/cytosolic fractionation was performed using a
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Fig. 1. HMGB1 oxidation mediated by PrxI and PrxII in the nucleus. (A) Mouse BMDMs were treated with 100 ng/mL LPS for various times, after which the
nuclear fraction of cell lysates was isolated and subjected to nonreducing SDS-PAGE and immunoblotting. The intensities of bands corresponding to oxidized (Ox)
forms of HMGB1 and to oxidized (dimeric) forms of PrxI and PrxII were determined. Means ± SEM (n=4). Re, reduced form. (B) Mechanistic scheme for the
formation of disulﬁde HMGB1 catalyzed by PrxI or PrxII. I-VI indicate the mechanistic process of reactions for HMGB1 disulﬁde formation by Prxs. (C, D) IP of
Myc–tagged human HMGB1(WT), HMGB1(C23S) or HMGB1(C45S) as well as with those for Myc/His6-tagged human PrxI or PrxII after 50 μMH2O2 for 30min
stimulation in HEK293T cells. (E) WCLs prepared in (C) and (D) were also separated into cytosolic and nuclear fractions before IP. Sp1 and GAPDH were used as
nucleus and cytoplasmic marker, respectively. (F) HEK293T cells were transfected with Myc-HMGB1(C23S) or Myc-HMGB1(C45S) and Myc/His6-tagged PrxI or
PrxII, and stimulated with 50 μMH2O2 at 30min. WCLs were subjected to 8% nonreducing SDS-PAGE. Black, blue, and red arrows show (Prx-Myc/His6)2, Myc-
HMGB1-Prx-Myc/His6, Myc-HMGB1-endogenous Prx complexes, respectively. *, (Prx-Myc/His6)2-Myc-HMGB1; **, Prx-Myc/His6-protein X complexes. Endo.: en-
dogenous. (G, H) A mixture (total of 1 ml) of HMGB1 (0.5 μg/ml) with either PrxI (0.4 μg/ml) or PrxII (0.4 μg/ml) proteins was treated with various concentrations of
DTT and 50 μMH2O2. The mixtures were immunoprecipitated with anti-HMGB1 Ab and immunoblotted with anti-PrxI/II Abs. Amounts of HMGB1-PrxI/II disulﬁde
intermediate were analysed with reducing SDS-PAGE. IgG, irrelevant Ab. (I, J) PLA assay for detection of the interaction between endogenous HMGB1 and PrxII. PLA
signal (red ﬂuorescence) were detected with antibodies HMGB1 and PrxII after1 μg/mL LPS for 1 h in MEFs or 50 μMH2O2 for 30min in HEK293T cells. Scale bars,
10 μm. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
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nuclear/cytosolic fractionation kit (BioVision Incorporated) according
to the manufacturer's procedure.
2.12. Statistical analysis
Analysis of experimental data was performed with the Student's t-
test using GraphPad Prism. Data represent the mean value and SEM or
SD, as indicated in the individual ﬁgure legends. The diﬀerence was
considered statistically signiﬁcant when p < 0.05.
3. Results
3.1. HMGB1 oxidation mediated by PrxI and PrxII in the nucleus
Ligation of TLR4 by LPS elicits H2O2 production through activation
of NADPH oxidase 4 (Nox4) [32]. To examine the eﬀect of LPS on the
formation of disulﬁde HMGB1, we stimulated mouse bone marrow–-
derived macrophages (BMDMs) with LPS and observed the formation of
oxidized form of HMGB1 (Fig. 1A). Disulﬁde HMGB1 is more compact
and thereby migrates faster in the electrophoretic gel compared with
reduced HMGB1. HMGB1 in the nucleus of unstimulated cells existed
predominantly in the fully reduced form. Stimulation with LPS, how-
ever, induced a time-dependent increase in the nuclear abundance of
disulﬁde HMGB1. H2O2 stimulation also induced a similar oxidation
eﬀect on PrxI, and PrxII (Fig. 1A, Suppl. Fig. 1A).
We examined the possibility that nuclear PrxI or PrxII might func-
tion as an H2O2 sensor and transducer for the formation of disulﬁde
HMGB1. PrxI and PrxII are obligate homodimers arranged in a head-to-
tail manner. In the presence of H2O2, the CP–SH residue (Cys52 for PrxI
and Cys51 for PrxII) is oxidized to sulfenic acid (CP–SOH), which then
reacts with the CR–SH residue (Cys173 for PrxI and Cys172 for PrxII) of
the other subunit to form a disulﬁde-linked dimer. As expected, neither
the higher-mobility form of HMGB1 nor dimeric PrxI/II was observed if
dithiothreitol (DTT) was added to the nuclear extracts before electro-
phoresis (Fig. 1A).
The putative Prx-mediated oxidation of HMGB1 would likely be
initiated by attack of the sulfenylated or disulﬁde Prx by either
Cys23–SH or Cys45–SH of HMGB1, resulting in the formation of a
transient intermolecular disulﬁde–linked intermediate containing both
Prx and HMGB1 (Fig. 1B). Resolution of the intermolecular disulﬁde by
either Cys23–SH or Cys45–SH of HMGB1, whichever does not participate
in the intermolecular disulﬁde linkage, would then result in regenera-
tion of reduced Prx and formation of disulﬁde HMGB1. To verify this
possibility by detection of the disulﬁde-linked HMGB1-Prx complex, we
transfected HEK293T cells with expression vectors for Myc epitope–-
tagged wild-type (WT) or Cys23-to-Ser (C23S) or Cys45-to-Ser (C45S)
mutant forms of HMGB1 as well as for Myc/His6-tagged forms of PrxI or
PrxII. The amount of Myc-HMGB1 that co-immunoprecipitated with
Myc/His6-tagged PrxI or PrxII from cell lysates was determined by IB
analysis after H2O2 stimulation. Immunoprecipitation (IP) of Myc-
HMGB1(C23S) and Myc-HMGB1(C45S) with Myc/His6-tagged PrxI or
PrxII was apparent in the absence of H2O2, and stimulation of the cells
with H2O2 greatly increased the extent of such IP (Fig. 1C and D). Si-
milar results were also obtained from IP of HMGB1 with PrxI/PrxII after
LPS stimulation (Suppl. Fig. 1B and C). Immunoprecipitate was also
detected in the PrxI(C173S)- and PrxII(C172S)-Myc/His6 with Myc-
HMGB1(C23S) after H2O2 stimulation (Suppl. Fig. 1D and E). And the
essential roles of the two cysteines of HMGB1 (Cys23 and Cys45) and of
PrxI/II (CP and CR) in formation of the intermolecular disulﬁde–linked
intermediates were demonstrated by analysis of HEK293T cells ex-
pressing a double mutant of either HMGB1(C23/45S) or PrxI(C52/
173S) or PrxII(C51/172S). So we hypothesized that those oxidized
(sulfenylated or disulﬁde) PrxI and PrxII recognize HMGB1 cysteine
and induce its disulﬁde formation (Fig. 1B). Preparation of nuclear and
cytosolic fractions from the whole cell lysates (WCLs) revealed that the
coprecipitation was apparent with the former fraction but not the latter,
where HMGB1 is mainly located (Fig. 1E). For detection of the HMGB1-
PrxI or PrxII complex form, HEK293T cells transfected with PrxI or
PrxII and HMGB1(C23S) or HMGB1(C45S) plasmids were stimulated
with H2O2. For detection of the HMGB1-PrxI or PrxII complex form,
HEK293T cells transfected with Myc/His6-tagged PrxI or PrxII and Myc-
HMGB1(C23S) or Myc-HMGB1(C45S) were stimulated with H2O2.
Binding complexes of His6-tagged PrxI or PrxII with HMGB1 from WCLs
were eluted using imidazole, and separated by nonreducing SDS-PAGE.
Coprecipitation was detected in the HMGB1-Prx intermolecular dis-
ulﬁde bond position; however, such complexes dissociated after DTT
treatment (Suppl. Fig. 1F and G). In addition, complex formation be-
tween HMGB1 and PrxI was also analysed by mass spectrometry. High
score peptide fragments of PrxI and HMGB1 from the protein band size
corresponding to the HMGB1-PrxI intermolecular complex were ob-
tained from cells expressing HMGB1(C23S) or HMGB1(C45S) with PrxI
or PrxII (Table S1). In cells overexpressing Myc/His6-tagged PrxI and
PrxII, amount of detected HMGB1-containing complex was notably
higher. The decreased mobility of theses complexes, caused by the
presence of Myc/His6-tagged PrxI and PrxII, suggests that these bands
represent a disulﬁde complex between PrxI or PrxII and HMGB1
(Fig. 1F). The disulﬁde-linked complexes of HMGB1-Prx and Prx-Prx-
HMGB1, which are from reactions I, II and III, IV, respectively (Fig. 1B),
were directly detected through analysis of WCLs by 8% and 12% non-
reducing SDS-PAGE (Fig. 1F, Suppl. Fig. 1H). Such complexes were
demonstrated in wild-type cells, which were disappeared in PrxI/II
double knockout (KO) HAP1 cells, after H2O2 stimulation [33]. And
higher molecular weight complexes of Prx with unidentiﬁed protein
(protein X) could be observed.
We also detected DTT-sensitive co-IP of puriﬁed PrxI or PrxII with
HMGB1 in the presence of H2O2 in vitro (Fig. 1G and H), conﬁrming the
formation of HMGB1-Prx disulﬁde intermediate. The amounts of PrxI
and PrxII in the nuclear fraction of HEK293T cells, Raw264.7 cells, and
MEFs were similar and in the range of 60–90 pg of each protein per
microgram of total nuclear protein (Suppl. Fig. 1I). These results in-
dicated that PrxI/II-mediated generation of disulﬁde HMGB1 occurs in
the nucleus via formation of an intermolecular disulﬁde as proposed in
Fig. 1B. The level of HMGB1-Prx disulﬁde intermediate formation was
decreased in PrxII-deﬁcient (KO) MEF cells, compared to that in wild-
type cells containing PrxI/II, after H2O2 stimulation (Suppl. Fig. 1J).
We performed a proximity ligation assay (PLA) to examine the close
binding between endogenous HMGB1 and PrxII proteins. LPS stimula-
tion induced a marked increase in the number of PLA signals in the
nucleus, indicative of a substantial extent of complex formation in MEFs
(Fig. 1I). The number of PLA signals due to the HMGB1-PrxII inter-
mediate was also greatly increased by exposure of the cells to H2O2 in
HEK293T cells (Fig. 1J). We also observed the close binding between
Myc–tagged WT, C23S, or C45S forms of HMGB1 and endogenous PrxII
proteins using HEK293T cells (Suppl. Fig. 1K-M). Treatment with H2O2
or GOX increased the number of PLA signals in the nucleus of cells
expressing each form of HMGB1. As expected, the number of PLA sig-
nals was greater in the cells expressing HMGB1(C23S) or
HMGB1(C45S) than in those expressing HMGB1(WT).
3.2. HMGB1 oxidation is decreased in PrxI or II-deﬁcient MEF cells
We next evaluated the eﬀect of the absence of PrxII on the formation
of disulﬁde HMGB1 with the use of immortalized WT and PrxII-KO
MEFs. The protein kinase C (PKC) activator PMA is thought to stimulate
HMGB1 secretion by inducing HMGB1 phosphorylation at serine re-
sidues located in the NLS sequences [4,34]. Like LPS, PMA also induces
H2O2 production by activating Nox enzymes [35]. Stimulation with LPS
or PMA increased the abundance of disulﬁde HMGB1 in WT and PrxII
KO MEFs, but this eﬀect was markedly attenuated in the latter cells
compared with the former for both stimulants (Fig. 2A and B). The
amount of disulﬁde HMGB1 produced in PrxII KO MEFs in response to
GOX or H2O2 treatment was increased greatly by ectopic expression of
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PrxII(WT) but was not aﬀected by that of PrxII(C172S) (Fig. 2C and D).
The CP residue (Cys51) of PrxII(C172S) is still sensitive to H2O2 and is
readily oxidized to sulfenic acid (CP–SOH). Inability of PrxII (C172S) to
mediate HMGB1 oxidation in PrxII KO MEFs suggests that PrxII eﬀec-
tively transfers its oxidation state to HMGB1 via the disulﬁde-linked
dimer. Resolving cysteine mutant Prxs maintain lesser interaction than
WT Prxs with HMGB1 and we believe the complex may have a very low
reaction rate in reaction V of Fig. 1B. Similar to the results obtained
with PrxI KO MEFs (Suppl. Fig. 2A and B). When we treated with cy-
cloheximide to rule out the eﬀect of newly synthesized cytoplasmic
HMGB1 to its oxidation, there was no eﬀect of newly synthesized
HMGB1 (Suppl. Fig. 2C).
Taken together, our data indicated that (1) both PrxI and PrxII sense
H2O2 and form a disulﬁde-linked homodimer for transduction of the
H2O2 signal by transfer of their oxidation state to HMGB1, thereby
generating disulﬁde HMGB1; (2) the transfer of oxidation state from the
Prx dimer to reduced HMGB1 involves formation of a Prx-HMGB1
complex linked by an intermolecular disulﬁde between the CP residue
of Prx and either Cys23 or Cys45 of HMGB1; and (3) the intermolecular
disulﬁde is resolved by the cysteine residue (Cys23 or Cys45) of HMGB1
not contributing to the intermolecular linkage, resulting in the pro-
duction of disulﬁde HMGB1. It is of note that HMGB1 oxidation occurs
in both PrxI and PrxII KO MEFs, albeit a reduced rate compared with
that in WT cells. This is likely because of the redundant function of PrxI
and PrxII. However, it was not possible to use PrxI/II knockdown cells
because they exhibited high levels of cell death in our study, which is
consistent with the very short life span of PrxI/II double KO mice [36].
To determine disulﬁde formation of HMGB1 Cys23–Cys45 and free
thiol of Cys106, Myc-tagged HMGB1 was transiently overexpressed in
HEK293T cells, treated with GOX for the formation of C23-C45 linked
disulﬁde HMGB1, and labeled the reactive cysteine residue using N-
ethylmaleimide (NEM) before or after DTT treatment for LC-MS/MS
analysis (Fig. 2E). Upon NEM labelling prior to DTT treatment, we
identiﬁed the mass shift of the NEM-tagged C106 peptide, but not of the
C23 or C45 peptide. Puriﬁed HMGB1 was also incubated with DTT for
dissociation of the C23-C45 disulﬁde linkage, and then subjected to
Fig. 2. Ablation of PrxII impedes formation of disulﬁde HMGB1. (A, B) Immortalized WT or PrxII KO MEFs were incubated for 30min in the absence or presence
of PMA (50 or 250 nM) or LPS (0.25 or 1 μg/mL), after which WCLs were subjected to nonreducing SDS-PAGE and immunoblotting. #: nonspeciﬁc bands, M,
monomer; D, dimer. (C, D) Immortalized PrxII KO MEFs that had been transfected with expression vectors for PrxII (C172S) or PrxII (WT) were incubated for 30min
in the absence or presence of GOX (0.5 or 5 mU/mL) or H2O2 (50 or 250 μM), after which WCLs were subjected to nonreducing SDS-PAGE. Means ± SEM (n=5 for
A and B, n = 3 for C and D). *P < 0.05, **P < 0.01 versus PrxII KO (A and B) or empty vector (Ev, C and D), t-test. (E) Determination of disulﬁde formation of
HMGB1 Cys23–Cys45 and free thiol of Cys106 by LC-MS/MS analysis. WCLs of GOX exposed Myc-HMGB1 in HEK293T cells were incubated with NEM and then treated
with DTT and NEM for disulﬁde HMGB1 analysis.
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NEM. We detected mass shift in both NEM-tagged C106 and C23 pep-
tides (Fig. 2E). We further calculated the degree of HMGB1 Cys23–Cys45
intramolecular disulﬁde formation. Fluorophore (Cy3 or Cy5)-tagged
maleimide, to tag free cysteine residues, was applied without or with
DTT (Suppl. Fig. 2D). HMGB1(WT) was similarly tagged with both
green (Cy3) and red (Cy5) ﬂuorescence, whereas the HMGB1(C23S)
mutant was tagged only with Cy3, indicating the formation of HMGB1
Cys23–Cys45 regardless of Cys106 oxidation state. HMGB1 Cys23–Cys45
intramolecular disulﬁde formation could be also demonstrated using
NEM and biotin-iodoacetamide (BIAM) analysis (Suppl. Fig. 2E).
3.3. Oxidation to the disulﬁde form is necessary for nucleocytoplasmic
translocation and secretion of HMGB1
We next examined the relevance of the oxidation of HMGB1 to the
disulﬁde form with regard to its nucleocytoplasmic translocation and
secretion. HEK293-hTLR4/MD2/CD14 cells were transfected with
EGFP-tagged HMGB1(WT), (C23S), or (C45S). LPS induced nucleocy-
toplasmic translocation of EGFP-tagged HMGB1(WT), whereas it had
no such eﬀect on HMGB1(C23S) or HMGB1(C45S), each of which forms
a disulﬁde-linked complex with PrxI/II that cannot be further resolved
to yield disulﬁde HMGB1 (Fig. 3A and B). IB analysis of culture su-
pernatants revealed that LPS induced the secretion of endogenous-
HMGB1 in MEFs (Fig. 3C). The secreted protein was judged to be the
disulﬁde form on the basis of the observation that its mobility on
Fig. 3. Oxidation of HMGB1 is required for nucleocytoplasmic translocation and secretion. (A, B) HEK293-hTLR4/MD2/CD14 cells expressing Myc/EGFP-
tagged WT, C23S, or C45S forms of HMGB1 were incubated with 1 μg/mL LPS for 2 h, and examined for EGFP ﬂuorescence by confocal microscopy (A). Scale bars,
10 μm. The percentage of cytoplasmic EGFP was determined (B). n > 200. (C) MEF cells were stimulated with LPS (50 or 250 ng/mL) for 24 h, after which culture
supernatants were harvested, and subjected to nonreducing SDS-PAGE with/without DTT. (D-F) MEF or HEK293T cells were incubated in the presence of 250 nM
PMA, 10 ng/mL TSA, 50 ng/mL TNFα, 2 mM NAC or 10 μM DPI for 24 h, after which culture supernatants were subjected to IB analysis. Means ± SEM (n = 3).
*P < 0.05, **P < 0.01, t-test. NS, not signiﬁcant. Dotted line is cut line of same membrane. (G-J) Oxidation eﬀect on phosphorylation or acetylation-defective
HMGB1. HMGB1 secretions of the phosphorylation-defective mutant HMGB1(NLS1/2A) and the acetylation-defective mutant HMGB1(NLS1/2R) were tested after
PMA, TSA, or GOX treatments. HMGB1 knockout MEF cells (I, J) were transfected with each plasmid for 36 h and stimulated for 24 h. Culture supernatants were
harvested and IB analyses were performed using an anti-Myc Ab. Means ± SEM (n = 3). *P < 0.05, **P < 0.01, t-test.
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nonreducing SDS-PAGE was decreased by the addition of DTT to the
culture supernatants (Fig. 3C).
We also observed the nucleocytoplasmic transport of Myc/EGFP-
HMGB1 induced by H2O2 or GOX in HEK293T cells as well as extra-
cellular secretion of Myc-HMGB1(WT) but not of Myc-HMGB1(C23S) or
Myc-HMGB1(C45S) (Suppl. Fig. 3A–D), suggesting that disulﬁde bond
formation between Cys23 and Cys45 is also required for H2O2-induced
HMGB1 translocation and secretion. Mutant protein overexpression had
no eﬀect on endogenous HMGB1 secretion and expression (Suppl.
Fig. 3C–E).
Like HMGB1 phosphorylation in PMA-treated cells, acetylation of
the NLS sequences of HMGB1 in cells treated with TSA promotes the
nuclear transport of HMGB1 toward secretion. Whereas PKC activation
by PMA results in H2O2 production through Nox activation [35], TSA-
induced acetylation of multiple mitochondrial proteins increases mi-
tochondrial H2O2 production [37]. Binding of TNFα to its cognate re-
ceptor induces both acetylation and phosphorylation of the NLS se-
quences of HMGB1 and thereby promotes HMGB1 secretion [3,4,38].
TNFα binding also induces H2O2 production from multiple sources in-
cluding mitochondria, Nox, and xanthine oxidase [39]. Treatment of
MEFs or HEK293T cells with PMA, TSA, or TNFα stimulated HMGB1
release in a manner sensitive to inhibition by the antioxidant N-acet-
ylcysteine (NAC) (Fig. 3D and E), suggesting that oxidant production
plays a key role in HMGB1 secretion. The Nox inhibitor diphenyle-
neiodonium (DPI) inhibited HMGB1 secretion induced by PMA but not
that induced by TNFα (Fig. 3F), suggesting that H2O2 produced by Nox
is required for PMA-induced HMGB1 secretion whereas non-Nox
sources of H2O2 such as mitochondria and xanthine oxidase are im-
portant for HMGB1 secretion induced by TNFα. Given that H2O2 aﬀects
many signaling pathways by targeting protein cysteine thiols, we ex-
amined whether the oxidation of Cys23 and Cys45 is also required for the
nuclear transport toward secretion of HMGB1 in response to PMA, TSA,
or TNFα. All three stimulants triggered the nucleocytoplasmic translo-
cation and secretion of Myc-HMGB1(WT) but not those of Myc-
HMGB1(C23S) or Myc-HMGB1(C45S) (Suppl. Fig. 3F–J).
We next tested whether a phosphorylation-defective mutant (NLS1/
2A, in which all six serines in the NLS1/2 sequences are replaced with
alanine) of HMGB1 [4] is secreted in response to oxidative stimuli.
Stimulation of HEK293T cells expressing Myc-HMGB1(WT) or (NLS1/
2A) with PMA or GOX revealed that secretion of the mutant protein did
occur in response to each stimulant but at a level lower than that ap-
parent for the WT protein, with secretion of both HMGB1(WT) and
HMGB1(NLS1/2A) being greatly attenuated by NAC (Fig. 3G and H).
Similar results were obtained with the acetylation-defective mutant
(NLS1/2R) [3], in which all six lysines in the NLS1/2 sequences are
replaced with arginines (Fig. 3I and J). These results suggested that
disulﬁde bond formation between Cys23 and Cys45 of HMGB1 is a
prerequisite for its secretion whereas acetylation or phosphorylation is
not suﬃcient.
Collectively, intramolecular disulﬁde bond formation between
Cys23 and Cys45 of HMGB1 is required for nucleocytoplasmic transport
toward secretion in response to all the stimulants tested (LPS, H2O2,
PMA, TSA, and TNFα). PTM such as phosphorylation and acetylation of
the NLS sequences appears not to be required for HMGB1 translocation
toward secretion but rather facilitates this process. PMA thus induced
the secretion of an HMGB1 mutant without NLS phosphorylation sites,
but the extent of this eﬀect was less pronounced than that apparent
with the WT protein. The observation that GOX-induced HMGB1 se-
cretion was also partially inhibited by NLS mutation is likely related to
the fact that PKC isoforms are activated by H2O2 independently of
diacylglycerol, the PKC activator mimicked by PMA [40].
3.4. Preferential binding of disulﬁde HMGB1 to CRM1
HMGB1 is suﬃciently small to undergo passive diﬀusion through
nuclear pores. Its nucleocytoplasmic translocation is also actively
regulated by the nuclear exportin CRM1, to which HMGB1 binds di-
rectly [3]. We examined the aﬃnity of HMGB1 for CRM1 with the use
of HEK293T cells transfected with expression vectors for CRM1 and
Myc–tagged WT, C23S, or C45S forms of HMGB1. IP revealed that
CRM1 binding to HMGB1(WT) was greatly increased by exposure of the
cells to H2O2 or GOX (Fig. 4A). In the treated cells, the apparent binding
aﬃnity of HMGB1 for CRM1 decreased in the rank order of WT >
C23S > C45S (Fig. 4A). Similar results were obtained by PLA analysis
of the proximity of the Myc–tagged forms of HMGB1 and endogenous
CRM1 (Fig. 4B). Together, these results thus indicated that the aﬃnity
of disulﬁde HMGB1 for CRM1 is greater than that of reduced HMGB1,
likely explaining the increased rate of nucleocytoplasmic translocation
of the disulﬁde form observed in the presence of various stimulants.
3.5. HMGB1 secretion from BMDMs is dependent on PrxI and PrxII
We next investigated the role of PrxI and PrxII in HMGB1 secretion
with the use of PrxI- or PrxII-KO BMDMs (Suppl. Fig. 4A). HMGB1 se-
cretion induced by LPS, PMA, TSA, TNFα, H2O2, or GOX was attenuated
in PrxI- or PrxII-KO BMDMs compared with WT BMDMs (Fig. 5A–D,
Suppl. Fig. 4B and C). As was the case for intramolecular disulﬁde
formation in nonimmune cells (Fig. 2A and B), the suppression of
HMGB1 secretion by PrxI or PrxII deﬁciency in BMDMs was partial.
Partial inhibition of HMGB1 secretion induced by LPS, PMA, TSA or
TNFα was also apparent in PrxI or II KO MEFs compared with WT
MEFs, whereas the extent of HMGB1 secretion was restored in the
mutant cells by forced expression of Prx (Fig. 5E and F).
3.6. LPS-induced HMGB1 secretion is dependent on PrxI and PrxII in vivo
We examined the role of PrxI and PrxII in HMGB1 secretion in vivo.
WT as well as PrxI- or PrxII-KO mice were injected intraperitoneally
with a sublethal dose (5mg/kg) of LPS, and blood samples were col-
lected at optimal times (1 and 16 h, respectively) for the measurement
of TNFα and HMGB1 concentrations in serum. LPS injection increased
TNFα levels to 22.0 ± 6.7 ng/mL in WT mice, to 15.7 ± 6.1 ng/mL in
PrxI-KO mice, and to 24.3 ± 6.9 ng/mL in PrxII-KO mice (Fig. 6A),
values that did not diﬀer signiﬁcantly from each other. In contrast, LPS
increased HMGB1 levels in PrxI- or PrxII-KO mice to 31.4 ± 13.6 and
43.6 ± 22.6 ng/mL, respectively, values that were signiﬁcantly
smaller than the corresponding value of 74.2 ± 14.7 ng/mL for WT
mice (Fig. 6B). PrxI and PrxII-KO mice had no diﬀerence in terms of
expression levels of various proteins related to inﬂuencing HMGB1
modiﬁcations (data not shown). Intramolecular oxidization of HMGB1
C23-45 is mediated by PrxI/II in the nucleus and its secretion me-
chanism is summarized in Fig. 7.
4. Discussion
HMGB1 passively leaks from necrotic and apoptotic cells of various
types and is actively secreted from live monocytes-macrophages in re-
sponse to stress signals. PTM such as acetylation or phosphorylation in
the residues of HMGB1 NLS sequences has been proposed as the major
mechanism for regulation of active nuclear exit of the protein. All sti-
mulants of HMGB1 secretion tested in this study (LPS, TNFα, PMA, and
TSA) are known to induce the intracellular production of H2O2 at low
levels, with oxidation of various protein cysteine residues by H2O2
being an important mechanism of cell signaling [41].
Here we found that oxidation of Cys23 and Cys45 to yield disulﬁde
HMGB1 is required for nucleocytoplasmic translocation and secretion
of the protein. The C23S and C45S mutants of HMGB1, which are not
able to form the intramolecular disulﬁde bond but in which acetylation
and phosphorylation sites are intact, thus manifested almost un-
detectable levels of nucleocytoplasmic translocation and secretion in
response to various stimulants. The dispensability of NLS phosphor-
ylation and acetylation for HMGB1 secretion was also demonstrated by
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the observation that the phosphorylation- and acetylation-defective
NLS1/2A and NLS1/2R mutants were still secreted in response to H2O2
stimulation. Despite the facts that oxidation of protein thiols is gen-
erally a slow process and that cellular compartments are equipped with
various H2O2-eliminating enzymes, the speciﬁc oxidation of HMGB1 by
H2O2 at low concentrations can be achieved in the nucleus as a result of
the H2O2 sensor and transducer function of PrxI and PrxII. Such a
function of PrxI and PrxII in the case of HMGB1 was demonstrated by
direct detection of the reaction intermediates comprising complexes of
HMGB1 and either PrxI or PrxII linked by an intermolecular disulﬁde
between the CP residue of PrxI/II and either Cys23 or Cys45 of HMGB1,
providing functional redundancy for HMGB1 oxidation. In high H2O2
concentrations, disulﬁde HMGB1 may proceed to the terminally oxi-
dized form of sulfonic HMGB1, which may be localized within the band
of disulﬁde HMGB1. However, the molecular mechanism requires fur-
ther investigation. Mullen et al. reported redox independency of
HMGB1 secretion, showing that HMGB1(C23S), HMGB1(C45S), and
HMGB1(C23S/C45S/C106S) were secreted following TNFα treatment
[42]. Although the underlying reason for this discrepancy remains
unclear, it might be possibly due to cell stress imposed by the serum-
free culture condition. Hopper et al. reported that HMGB1(C23S) and
HMGB1(C45S) mutant forms are localized within the nuclear space
after starvation stress, which is consistent with our data [43].
On the basis of our ﬁndings, we propose a model for the mechanism
underlying regulated HMGB1 secretion from monocytes and macro-
phages. Inﬂammatory stimuli such as LPS and TNFα as well as chemical
agents such as PMA and TSA induce H2O2 production from multiple
sources including Nox and mitochondria in the cytoplasm, and the
H2O2 molecules then diﬀuse to the nucleus. It is also likely that H2O2
produced as a result of the respiratory burst of neighboring neutrophils
and macrophages can enter the cell and reach the nucleus, and that
activation of Nox enzymes localized at the nuclear membrane may be a
source of nuclear H2O2 [44,45]. Prx isoforms (I to VI) are abundantly
present in the cytosol, mitochondria, ER, and/or peroxisome etc. In
spite of high expression level of cytosolic PrxI or PrxII, PrxI/II bound to
HMGB1 in the nucleus may use nuclear H2O2 for its interaction. The
accumulation of H2O2 in the nucleus is ﬁrst sensed by PrxI and PrxII,
resulting in the rapid oxidation of CP and CR of each enzyme and the
consequent formation of intersubunit disulﬁde bonds in each dimer.
The oxidized PrxI or PrxII then transfers its oxidation state to reduced
HMGB1 to generate disulﬁde HMGB1 with an intramolecular disulﬁde
between Cys23 and Cys45. Disulﬁde HMGB1 is preferentially trans-
ported out of the nucleus as a result of its binding to the nuclear ex-
portin CRM1 with higher aﬃnity compared with that of reduced
HMGB1—although, given that disulﬁde HMGB1 is more compact than
the reduced form, preferential passive diﬀusion of disulﬁde HMGB1
cannot be excluded. It is also possible that, like acetylated HMGB1,
disulﬁde HMGB1 may be less favored for nuclear import and thus ac-
cumulates in the cytosol. Disulﬁde HMGB1 in the cytosol is packed into
lysosomes through an as yet unknown mechanism and is then secreted.
In our study, we cannot clearly explain why HMGB1 oxidation re-
quires both PrxI and PrxII. We propose two kinds of possibility. First,
HMGB1 proteins comprise ubiquitous, abundant nuclear proteins, the
oxidative stage of which plays a critical role in the response to in-
ﬂammatory stimuli. The concentration of PrxI and PrxII, however, is
very limited in the nuclei of various cell lines (Suppl. Fig. 1H), requiring
Fig. 4. Binding of disulﬁde HMGB1 to CRM1. (A) IP of Myc–tagged HMGB1(WT), HMGB1(C23S) or HMGB1(C45S) with CRM1 after 50 μMH2O2 or 0.5 mU/mL
GOX for 2 h stimulation in HEK293T. (B) HEK293T cells expressing Myc–tagged WT, C23S, or C45S forms of HMGB1 were incubated in the absence or presence of
50 μMH2O2 or GOX (5 mU/mL) for 2 h and then subjected to a PLA assay with antibodies to Myc and to CRM1. Scale bars, 10 μm.
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them to independently control the oxidation eﬀect of HMGB1, thereby
oﬀering rapid and eﬀective response to HMGB1 oxidation and in-
ﬂammatory signaling. Second, thioredoxins are known to rapidly re-
duce disulﬁde HMGB1 to reduced HMGB1 [43]. Moreover, Prx has been
reported to promote thioredoxin oxidation, in particular in cases of Prx-
dependent Pap1 oxidation [46,47], along with PrxIV-mediated PDI
oxidation in the ER [23,24]. PrxI or PrxII-mediated thioredoxin oxi-
dation could result in the inhibition of HMGB1 reduction. In addition,
depletion of cytosolic 2-Cys Prxs dramatically abolishes rapid protein
thiol oxidation in an H2O2-dependent manner [33]. Therefore, the ex-
istence of the other antioxidant-dependent HMGB1 oxidation mechan-
isms cannot be ruled out.
Our study of HMGB1 oxidation was performed in an intracellular
environment. Released HMGB1 can also be oxidized in extracellular
environments such as human serum, saliva, and in cell culture medium
with varying cell conﬂuency. The reduced form of HMGB1 produced
from E. coli could also be oxidized to the disulﬁde form within ap-
proximately ∼50min in serum under ambient conditions in vitro,
suggesting that Prx-independent HMGB1 oxidation is possible outside
of cells. Considering that Prx could be secreted in an inﬂammatory
condition [42] and our unpublished observation], both PrxI/II-depen-
dent and independent mechanisms of HMGB1 oxidation are possible in
the extracellular space. A more complete understanding of the oxida-
tion kinetics of the reduced form of HMGB1, which is released from
Fig. 5. Deﬁciency of PrxI or PrxII at-
tenuates HMGB1 secretion in BMDMs
and vice versa. (A-D) BMDMs derived from
WT, PrxI-KO (PrxI–/–), or PrxII-KO (PrxII–/–)
mice were incubated in the absence or
presence of 100 ng/mL LPS, 250 nM PMA,
50 ng/mL TSA, or 50 ng/mL TNFα for 24 h,
after which culture supernatants were sub-
jected to IB analysis. Means ± SEM
(n=3). (E, F) PrxII KO MEF cells were
transfected with PrxII plasmid and in-
cubated with the indicated concentrations
of LPS (ng/mL) (E) or GOX (μU/ml) (F) for
24 h, after which culture supernatants were
subjected to IB analysis. WT MEF cells were
used for positive control. Means ± SEM
(n = 3). *P < 0.05, **P < 0.01 versus
corresponding value for PrxII KO cells, t-
test.
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damaged tissue, and the oxidation mechanism of disulﬁde to sulfonic
HMGB1 are necessary to predict the fate of HMGB1-mediated in-
ﬂammation in tissue. H2O2 sensor and transducer function of PrxI and
PrxII might also be needed in the cytosol to maintain HMGB1 in the
disulﬁde form before it is packaged into lysosomes. Our results show
that HMGB1 that is actively secreted in response to LPS stimulation is
present in the disulﬁde form, not the reduced form.
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Increasing of nuclear H2O2 leads to nuclear
PrxI/II oxidation step by step, oxidized to
sulfenic acid (CP-SOH) and then reacts with
the CR-SH residue to disulﬁde-linked dimer.
Sulfenic or disulﬁde Prx can initially attack
either Cys23-SH or Cys45-SH of HMGB1, re-
sulting in the formation of intramolecular
disulﬁde-bond (disulﬁde HMGB1). Disulﬁde
HMGB1 formation in the nucleus by PrxI/II
induces nucleocytoplasmic translocation in
CRM1 dependent manner and then extra-
cellular secretion.
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